Our study demonstrated that the non-smoker with TIMP-3 SNP rs9619311 TC + CC genotype may be under higher risk of muscle invasive tumor development, thus these patients may be suitable to receive aggressive therapy at the early stage while further experiments are needed to support this concept. Here, TIMP3 is linked to neoplasm.